Adrian Koh

3.8k total citations · 3 hit papers
33 papers, 2.7k citations indexed

About

Adrian Koh is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Adrian Koh has authored 33 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Ophthalmology, 23 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Molecular Biology. Recurrent topics in Adrian Koh's work include Retinal Diseases and Treatments (26 papers), Retinal Imaging and Analysis (20 papers) and Retinal and Optic Conditions (15 papers). Adrian Koh is often cited by papers focused on Retinal Diseases and Treatments (26 papers), Retinal Imaging and Analysis (20 papers) and Retinal and Optic Conditions (15 papers). Adrian Koh collaborates with scholars based in Singapore, Japan and Switzerland. Adrian Koh's co-authors include Frank G. Holz, Pravin U. Dugel, Yuichiro Ogura, Glenn J. Jaffe, Ursula Schmidt‐Erfurth, Timothy Y. Y. Lai, Won Ki Lee, Paisan Ruamviboonsuk, Tock Han Lim and Lee-Jen Chen and has published in prestigious journals such as Ophthalmology, Frontiers in Immunology and American Journal of Ophthalmology.

In The Last Decade

Adrian Koh

33 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration

2019 623 citations Pravin U. Dugel, Adrian Koh et al. Ophthalmology profile →
HAWK and HARRIER

2020 260 citations Pravin U. Dugel, Rishi P. Singh et al. Ophthalmology profile →
Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy

2017 214 citations Adrian Koh, Timothy Y. Y. Lai et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adrian Koh Singapore	18	2.4k	1.6k	311	154	146	33	2.7k
Thibaud Mathis France	20	1.0k 0.4×	597 0.4×	129 0.4×	32 0.2×	66 0.5×	115	1.2k
Jiro Numaga Japan	22	895 0.4×	203 0.1×	150 0.5×	134 0.9×	206 1.4×	64	1.2k
Oudy Semoun France	23	1.3k 0.5×	1.0k 0.6×	105 0.3×	27 0.2×	65 0.4×	66	1.5k
Daniel B. Roth United States	21	1.4k 0.6×	823 0.5×	148 0.5×	41 0.3×	78 0.5×	74	1.6k
Toshikatsu Kaburaki Japan	24	1.3k 0.6×	200 0.1×	189 0.6×	90 0.6×	259 1.8×	109	1.7k
Carmen K. M. Chan Hong Kong	23	1.3k 0.5×	870 0.5×	137 0.4×	53 0.3×	162 1.1×	65	1.6k
Albert T. Vitale United States	20	1.4k 0.6×	219 0.1×	227 0.7×	159 1.0×	103 0.7×	56	1.8k
Alessandro Marchese Italy	20	1.1k 0.5×	591 0.4×	210 0.7×	43 0.3×	106 0.7×	122	1.4k
Afshan Nanji United States	16	819 0.3×	411 0.2×	91 0.3×	71 0.5×	221 1.5×	26	1.0k
W J Stark United States	17	568 0.2×	666 0.4×	93 0.3×	312 2.0×	124 0.8×	51	1.0k

Countries citing papers authored by Adrian Koh

Since Specialization

Citations

This map shows the geographic impact of Adrian Koh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Koh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Koh more than expected).

Fields of papers citing papers by Adrian Koh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian Koh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Koh. The network helps show where Adrian Koh may publish in the future.

Co-authorship network of co-authors of Adrian Koh

This figure shows the co-authorship network connecting the top 25 collaborators of Adrian Koh. A scholar is included among the top collaborators of Adrian Koh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian Koh. Adrian Koh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wong, Wendy, Yvonne Loh, Hwei Wuen Chan, et al.. (2025). Hematopoietic stem cell transplantation as rescue therapy for refractory autoimmune retinopathy: a case report. Frontiers in Immunology. 15. 1484798–1484798. 1 indexed citations

Teo, Kelvin Yi Chong, Bora Eldem, Antonia M. Joussen, et al.. (2024). Treatment regimens for optimising outcomes in patients with neovascular age-related macular degeneration. Eye. 39(5). 860–869. 1 indexed citations

Ngah, Nor Fariza, et al.. (2023). Guidelines from an expert panel for the management of diabetic macular edema in the Malaysian population. International Journal of Ophthalmology. 16(5). 712–720. 3 indexed citations

Regillo, Carl D., Rishi P. Singh, Robin Hamilton, et al.. (2022). Fluid Control in Neovascular Age-Related Macular Degeneration with Brolucizumab: An Analysis of the HAWK and HARRIER Phase 3 Trials. Ophthalmologica. 245(5). 403–412. 11 indexed citations

Korobelnik, Jean‐François, Anat Loewenstein, Bora Eldem, et al.. (2021). Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure. Graefe s Archive for Clinical and Experimental Ophthalmology. 259(3). 567–574. 14 indexed citations

Singh, Rishi P., Chirag Jhaveri, Charles C. Wykoff, et al.. (2021). Efficacy Outcomes of Brolucizumab Versus Aflibercept in Neovascular Age-Related Macular Degeneration Patients with Early Residual Fluid. Ophthalmology Retina. 6(5). 377–386. 8 indexed citations

Ogura, Yuichiro, Glenn J. Jaffe, Chui Ming Gemmy Cheung, et al.. (2021). Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK. British Journal of Ophthalmology. 106(7). 994–999. 37 indexed citations

Dugel, Pravin U., Rishi P. Singh, Adrian Koh, et al.. (2020). HAWK and HARRIER. Ophthalmology. 128(1). 89–99. 260 indexed citations breakdown →

Korobelnik, Jean‐François, Anat Loewenstein, Bora Eldem, et al.. (2020). Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic. Graefe s Archive for Clinical and Experimental Ophthalmology. 258(6). 1149–1156. 97 indexed citations

10.

Nguyen, Quan Dong, Arup Das, V. Diana, et al.. (2020). Brolucizumab: Evolution through Preclinical and Clinical Studies and the Implications for the Management of Neovascular Age-Related Macular Degeneration. Ophthalmology. 127(7). 963–976. 169 indexed citations

11.

Chhablani, Jay, Kelvin Wong, Gavin Siew Wei Tan, et al.. (2020). Diabetic Macular Edema Management in Asian Population: Expert Panel Consensus Guidelines. Asia-Pacific Journal of Ophthalmology. 9(5). 426–434. 25 indexed citations

12.

Koh, Adrian, Timothy Y. Y. Lai, Wen Bin Wei, et al.. (2019). REAL-WORLD EFFECTIVENESS AND SAFETY OF RANIBIZUMAB TREATMENT IN PATIENTS WITH AND WITHOUT POLYPOIDAL CHOROIDAL VASCULOPATHY. Retina. 40(8). 1529–1539. 10 indexed citations

13.

Dugel, Pravin U., Adrian Koh, Yuichiro Ogura, et al.. (2019). HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration. Ophthalmology. 127(1). 72–84. 623 indexed citations breakdown →

14.

Ishibashi, Tatsuro, Xiaoxin Li, Adrian Koh, et al.. (2015). The REVEAL Study. Ophthalmology. 122(7). 1402–1415. 140 indexed citations

15.

Laude, Augustinus, et al.. (2013). Does retinitis pigmentosa cause depression. Investigative Ophthalmology & Visual Science. 54(15). 678–678. 1 indexed citations

16.

Bandello, Francesco, Frank G. Holz, Mark C. Gillies, Adrian Koh, & Paul Mitchell. (2012). Safety, Efficacy, And Treatment Patterns Of Ranibizumab Therapy For Neovascular Age-Related Macular Degeneration: The LUMINOUS Studies. Investigative Ophthalmology & Visual Science. 53(14). 2031–2031. 2 indexed citations

17.

Koh, Adrian, Won Ki Lee, Lee-Jen Chen, et al.. (2012). EVEREST STUDY. Retina. 32(8). 1453–1464. 456 indexed citations

18.

Koh, Adrian, et al.. (2008). Bietti’s crystalline dystrophy in Asians: clinical, angiographic and electrophysiological characteristics. International Ophthalmology. 29(6). 459–470. 19 indexed citations

19.

Pettway, Glenda J., Adrian Koh, Effendi Widjaja, et al.. (2005). Anabolic actions of PTH (1-34): Use of a novel tissue engineering model to investigate temporal effects on bone. Bone. 36(6). 959–970. 66 indexed citations

20.

Lim, Wee-Kiak, et al.. (2004). Ocular manifestations of dengue fever☆. Ophthalmology. 111(11). 2057–2064. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact